SCHEMBL467443

SCHEMBL467443

CCN(CC)C(=O)c1ccc(OBOc2ccc(C(=O)N(CC)CC)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
LMNA P02545 3/20 0.56
MAPT P10636 2/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
HPGD P15428 5/20 0.54
MLYCD O95822 1/20 0.53
OPRM1 P35372 2/20 0.49
OPRD1 P41143 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HRH3 Q9Y5N1 1/20 0.48
HSP90AA1 P07900 3/20 0.47
HSP90AB1 P08238 3/20 0.47
CYP1A2 P05177 1/20 0.47
BLM P54132 1/20 0.47
TSHR P16473 1/20 0.47
PDE4A P27815 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5703500 0.82 HPGD (0.73) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL1844719 0.81 OPRM1 (0.67) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL5095020 0.80 HPGD (0.59) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL4472661 0.80 NPC1 (0.82) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL177478 0.79 HPGD (0.68) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL1495914 0.79 MEN1 (0.79) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL6308636 0.77 HPGD (0.67) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL7166974 0.77 MAPT (0.63) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL27649211 0.77 ALDH1A1 (0.55) ALDH1A1LMNAMAPTRAB9ANPC1
SCHEMBL6770181 0.77 KMT2A (0.58) ALDH1A1LMNAMAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675847-B1 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORP (US) 2012-12-05 EP disclosed
EP-2399577-A1 Use of N-containing spirocompounds for the enhancement of cognitive function Adolor Corporation (US) 2011-12-28 EP disclosed
EP-1675847-A4 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORP (US) 2008-08-20 EP disclosed
EP-1675847-A2 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE Adolor Corporation (US) 2006-07-05 EP disclosed
WO-2005033073-A2 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2005-04-14 WO disclosed